References
1a
Hopkins FG.
Nature (London)
1889,
40:
335
1b
Hopkins FG.
Nature (London)
1891,
45:
197
1c
Hopkins FG.
Nature (London)
1892,
45:
581
2
Mitchell HK.
Snell EE.
Williams RJ.
J. Am. Chem. Soc.
1941,
63:
2284
3
Scott JM.
Weir DG.
Kirke P.
In Folate and Neural Tube defects. Folate in
Health and Disease
Chap. 12:
Bailey
L. B., Marcel Dekker;
New York:
1994.
p.329
4a
Taylor EC.
Palmer DC.
George TJ.
Fletcher SR.
Tseng CP.
Harrington PJ.
Beardsley GP.
J. Org. Chem.
1983,
48:
4852
4b
DeGraw JI.
Christie PH.
Colwell WT.
Sirotnak FM.
J.
Med. Chem.
1992,
35:
320
4c
Borrell JI.
Teixidó J.
Matallana JL.
Martínez-Teipel B.
Colominas C.
Costa M.
Balcells M.
Schuler E.
Castillo MJ.
J. Med. Chem.
2001,
44:
2366
5
Grivsky EM.
Lee S.
Sigel CW.
Duch DS.
Nichol CA.
J.
Med. Chem.
1980,
23:
327
6a
Matsumoto J.
Minami S.
J.
Med. Chem.
1975,
18:
74
6b
Suzuki N.
Chem.
Pharm. Bull.
1980,
28:
761
6c
Oakes V.
Rydon HN.
J. Chem. Soc.
1956,
4433
6d
DeGraw JI.
Kisliuk RL.
Gaumont Y.
Baugh CM.
J.
Med. Chem.
1974,
17:
470
6e
Zakharov AV.
Gavrilov MY.
Novoselova GN.
Vakhrin MI.
Konshin ME.
Khim-Farm. Zh.
1996,
30:
39
7
Deyanov AB.
Niyazov RK.
Nazmetdinov FY.
Syropyatov BY.
Kolla VE.
Konshin ME.
Khim-Farm. Zh.
1991,
25:
26
8 Heckler RE, and Jourdan GP. inventors; Eur. Patent 414 386.
; Chem. Abstr. 1991, 115, 71630
9
Bagley MC.
Hughes DD.
Lloyd R.
Powers VEC.
Tetrahedron
Lett.
2001,
42:
6585
10
Bagley MC.
Dale JW.
Hughes DD.
Ohnesorge M.
Phillips NG.
Bower J.
Synlett
2001,
1523
11
Bagley MC.
Singh N.
Chem. Commun.
2001,
2438
12
Quiroga J.
Cisneros C.
Insuasty B.
Abonía R.
Nogueras M.
Sánchez A.
Tetrahedron Lett.
2001,
42:
5625
13 In a typical experimental procedure,
a mixture of 1,3-diaminopyrimidin-4-one 1 (0.20
g, 1.6 mmol), benzaldehyde (0.34 g, 3.2 mmol), ethyl acetoacetate
(0.41 g, 3.2 mmol) and zinc(II) bromide (0.072 g, 0.32 mmol) in
DMSO (7 mL) was irradiated for 20 min in a self-tunable CEM microwave synthesizer
at 160 °C (initial power 30 W) and then allowed to cool.
Water (25 mL) was added and the solution was left to stand for 5-6
h. The precipitated solid was filtered and washed with ethyl acetate
to give 5-deaza-5-dihydropterin (3a) (0.38
g, 80%) as a pale yellow solid, mp 179-180 °C (Found:
MH+, 327.1454. C17H18N4O3 requires
MH, 327.1457); IR (KBr)/cm-1:
3317, 3206, 2936, 1660, 1599, 1515, 1455, 1367, 1285, 1224, 1106,
1024; 1H NMR (DMSO-d
6;
400 MHz) δ (ppm) 10.34 (1 H, 3, 3-H), 9.06 (1 H, s, 8-H),
7.24-7.00 (5 H, m, PhH), 6.27 (2 H, s, NH2),
4.82 (1 H, s, 5-H), 3.94 (2 H, q, J = 7.0
Hz, CH2), 2.31 (3 H, s,
7-Me), 1.10 (3 H, t, J = 7.0 Hz, Me); 13C
NMR (DMSO-d
6; 100
MHz) δ (ppm) 167.2 (C), 161.8 (C), 154.4 (C), 154.3 (C),
148.5 (C), 147.5 (C), 128.0 (CH), 127.6 (CH), 125.9 (CH), 101.5
(C), 91.4 (C), 59.2 (CH), 36.8 (CH2), 18.8 (Me), 14.5
(Me); m/z (APcI) 327 (MH+,
100%), 79 (67).